Aspira Women's Health Inc.
AWHL Healthcare Diagnostics & Research
In the quarter to June 2026, revenue fell 14.9%, EPS grew 28.6%, free cash flow fell 24.6% and total debt rose 25.9%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for five, operating cash flow growth for three; insiders bought in the last twelve months.
Follow AWHL
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
(14.97) | (10.50) | (11.37) | (15.24) | (17.90) | (31.66) | (29.88) | (16.69) | (13.09) | (12.78) |
Depreciation & Amortization |
0.72 | 0.79 | 0.68 | 0.33 | 0.27 | 0.30 | 0.26 | 0.20 | 0.09 | 0.11 |
Non Cash Items (Other) |
1.19 | 1.44 | 1.11 | 1.25 | 1.58 | 2.57 | 1.35 | 0.37 | 0.19 | 7.75 |
Accounts Receivable Change |
(0.19) | 0.07 | (0.08) | (0.14) | 0.06 | (0.16) | (0.22) | (0.21) | 0.47 | (0.22) |
Change in inventories |
(0.01) | (0.01) | 0.01 | 0.07 | 0.00 | (0.14) | (0.14) | 0.09 | (0.10) | 0.07 |
Change in payables and accrued liability |
(0.85) | 0.05 | 0.38 | 0.97 | 1.59 | 2.25 | (2.46) | (0.16) | 0.49 | (2.08) |
Change in other assets and liabilities |
0.14 | 0.03 | (0.09) | (0.21) | (0.32) | (0.55) | 0.02 | 0.51 | (0.17) | 0.12 |
Operating Cash Flow |
(13.96) | (8.13) | (9.37) | (12.96) | (14.73) | (27.39) | (31.07) | (15.89) | (12.11) | (7.03) |
Capital expenditures |
(1.26) | (0.06) | (0.11) | (0.13) | (0.49) | (0.18) | (0.23) | (0.02) | (0.04) | (0.02) |
Change in intangibles (net) |
— | — | — | — | — | — | — | — | — | (0.38) |
Investing cash flow |
(1.26) | (0.06) | (0.11) | (0.13) | (0.49) | (0.18) | (0.23) | (0.02) | (0.04) | (0.40) |
Repayment/Issuance of Debt (Net) |
1.82 | (0.22) | (0.21) | (0.19) | 2.81 | (0.20) | (0.26) | (0.15) | (0.09) | 1.13 |
Equity Repurchase (Common, Net) |
0.01 | 8.70 | 9.02 | 15.63 | 6.70 | 48.58 | 9.01 | 4.92 | 0.90 | 3.60 |
Equity Repurchase (Preffered, Net) |
— | — | 4.50 | — | — | (0.38) | (0.21) | — | — | — |
Other financial activities |
1.19 | 1.44 | 1.11 | 1.25 | 10.64 | 2.53 | (1.32) | 0.45 | 10.25 | 2.69 |
Financing cash flow |
1.82 | 8.49 | 13.30 | 15.44 | 20.15 | 48.38 | 7.43 | 5.22 | 11.06 | 7.42 |
Change in Cash |
(13.40) | 0.30 | 3.82 | 2.34 | 4.93 | 20.80 | (23.87) | (10.70) | (1.09) | (0.01) |
Beginning Cash |
18.64 | 5.24 | 5.54 | 9.36 | 11.70 | 16.63 | 37.43 | 13.56 | 2.86 | 1.77 |
Ending Cash |
5.24 | 5.54 | 9.36 | 11.70 | 16.63 | 37.43 | 13.56 | 2.86 | 1.77 | 1.76 |
Stock Based Compensation |
1.18 | 1.44 | 1.10 | 1.19 | 1.55 | 3.54 | 2.41 | 1.72 | 1.49 | 0.53 |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(0.90) | 0.14 | 0.22 | 0.69 | 1.33 | 1.39 | (2.80) | 0.23 | 0.70 | (2.11) |
Issuance/Purchase of Shares |
0.01 | 8.70 | 13.52 | 15.63 | 6.70 | 48.58 | 9.01 | 4.92 | 0.90 | 3.60 |
| Other line items | ||||||||||
Revenue per Employee |
0.08 | 0.08 | 0.07 | 0.09 | 0.07 | 0.06 | 0.10 | 0.14 | 0.14 | 0.24 |